Rossari Biotech Unitop Completes Major Chemical Expansion

Rossari Biotech announced that its subsidiary, Unitop Chemicals Private Limited, has completed its planned 30,000 MTPA ethoxylation capacity expansion at its Dahej facility. The final 15,000 MTPA phase is effective March 31, 2026, bringing Unitop's total installed ethoxylation capacity to 66,000 MTPA. This expansion significantly enhances Unitop's production capabilities in the specialty chemicals segment.

This strategic expansion is designed to meet growing demand for ethoxylated products in key sectors such as agrochemicals, home and personal care, and oil & gas. Unitop's enhanced operational capability in this specialty chemicals niche positions it well for future market opportunities.

This latest capacity addition follows the commissioning of the first 15,000 MTPA phase in September 2025, which raised Unitop's total capacity to 51,000 MTPA. The company had also secured adjacent land rights to facilitate further growth and operational synergies.

With the full expansion online, Unitop gains substantial production potential to capture greater market share and offer customers improved supply chain reliability.

However, the expansion comes amid significant market pressure for Rossari Biotech. The company's stock has recently reached all-time lows, underperforming market benchmarks. Recent financial results for Q3 FY26 showed quarter-on-quarter declines in revenue, operating profit, and net profit, despite modest year-over-year revenue growth. Investors are also monitoring concerns around free cash flow generation, which fell short of statutory profit in the year to September 2025, alongside deteriorating metrics like interest coverage and Return on Capital Employed (ROCE).

Unitop operates in a competitive landscape. Key peers in specialty chemicals include Galaxy Surfactants, known for its strong presence in home and personal care ingredients and significant ethoxylation capacity. Aarti Industries also has ethylation capacity at its Dahej SEZ, serving agrochemicals and polymers. Godrej Industries (Chemicals Division) is another major player with substantial overall chemical production capacity.

The Indian specialty chemicals market is a significant growth area, projected to expand at a CAGR of 10-12% and reach $40 billion by 2025.

Investors will be watching Unitop's capacity utilization rates following the expansion. Key focus areas include the impact of the increased production on Rossari Biotech's overall financial performance, its ability to manage profitability pressures, and cash flow generation. Competitive dynamics with players like Galaxy Surfactants, Aarti Industries, and Godrej Industries will also be closely monitored.